Mylan will pay $465 million to resolve accusations from some regulators that it overbilled the federal Medicaid program for the EpiPen allergy medication, the drugmaker announced Friday.
Oct 7, 2016
The internal watchdog of the U.S. Department of Health and Human Services blames the often-substandard quality of care at hospitals serving Native Americans on outdated equipment and technology, lack of resources and difficulty ...
Oct 7, 2016
Does religion affect people's likelihood of being screened for cancer? That's the question Dr. Aisha Lofters and her team at St. Michael's Hospital are trying to answer.
Oct 7, 2016
